Human Recombinant SORD proteins
- Known as:
- Human Recombinant SORD proteins
- Catalog number:
- 6388-100
- Product Quantity:
- 100 μg
- Category:
- Proteins
- Supplier:
- Biovis
- Gene target:
- Human Recombinant SORD proteins
Related genes to: Human Recombinant SORD proteins
- Gene:
- SORD NIH gene
- Name:
- sorbitol dehydrogenase
- Previous symbol:
- -
- Synonyms:
- -
- Chromosome:
- 15q21.1
- Locus Type:
- gene with protein product
- Date approved:
- 2001-06-22
- Date modifiied:
- 2016-10-05
Related products to: Human Recombinant SORD proteins
Related articles to: Human Recombinant SORD proteins
- To examine literature on cultural competence in audiology services for Deaf adult sign language users, identifying themes, evidence gaps, and systemic barriers to inclusive care. - Source: PubMed
Publication date: 2026/05/11
Hulme CeliaRogers KatherineYoung AlysMunro Kevin J - This study aims to delineate the molecular mechanisms through which aristolochic acid (AA) exposure drives renal cell carcinoma (RCC) pathogenesis, leveraging an integrated machine learning (ML) and multi-omics approach to systematically identify and validate key targets linking AA to RCC development. - Source: PubMed
Publication date: 2026/04/18
Zhang FanHan ShuaiPan DanGao LinaSong Weijie - To develop an assay to measure red blood cell (RBC) sorbitol dehydrogenase (SORD) activity for fast laboratory screening of SORD-related neuropathies, and to provide additional phenotypic arguments in case of ambiguous genetic results. - Source: PubMed
Moro NicholasFrancois StanislasGrondin ChristelBen Salem SirineRajagopal SreekanthAykut DuruArezki LouisaLarramendi José ManuelBerquet ClaireWillems MarjolaineBouchet-Séraphin CélineGauthier Lucas WKonyukh MarinaSvahn JulietteMoutereau StéphanePeoc'h KatellTard CélineFernández-Eulate GorkaStojkovic TanyaBruneel ArnaudRaynor Alexandre - - Source: PubMed
Publication date: 2026/04/16
Taoka ToshiakiIto RintaroIwamoto KunihiroMiyata SeikoNakamichi ReiNakane ToshikiIima MamiFujishiro HiroshigeIkeda MasashiIchikawa KazushigeKamiunten AkifumiIchinose NobuyasuTanaka YoshikiNaganawa Shinji - Neuroblastoma (NB) progression is influenced by metabolic and redox adaptations. The polyol pathway, driven by aldose reductase (AKR1B1) and sorbitol dehydrogenase (SORD), is activated in hyperglycemic conditions, while detoxification of lipid peroxidation products such as 4-hydroxynonenal (4-HNE) involves carbonyl reductase 1 (CBR1) and AKR1B1. A systematic characterization of these enzymes under distinct metabolic and oxidative challenges in NB is currently lacking. - Source: PubMed
Publication date: 2026/02/27
Avanatti MartinaSardelli GemmaMosca RossellaBalestri FrancescoSignore GiovanniFelice FrancescaDel Corso AntonellaMoschini Roberta